SOPHiA GENETICS (SOPH) Shares Outstanding (Weighted Average) (2020 - 2025)

SOPHiA GENETICS has disclosed Shares Outstanding (Weighted Average) across 6 years of filings, most recently posting $4.8 million for Q4 2025.

• Shares Outstanding (Weighted Average) for Q4 2025 came in at $4.8 million, down 92.78% year-over-year; the trailing twelve-month figure through Dec 2025 was $4.8 million (down 92.78% YoY), and the FY2025 annual result was $4.8 million, down 92.78% from the prior year.
• Shares Outstanding (Weighted Average) came in at $4.8 million for Q4 2025 at SOPHiA GENETICS, down from $472.4 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $472.4 million in Q3 2025 to a low of $60.0 in Q1 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $231.9 million (2021), against an average of $249.2 million.
• Across the five-year window, Shares Outstanding (Weighted Average) surged 786284900.0% in 2023 and tumbled 100.0% in 2024, its largest moves.
• SOPHiA GENETICS's Shares Outstanding (Weighted Average) stood at $55.3 million in 2021, then rose by 15.91% to $64.1 million in 2022, then grew by 1.02% to $64.8 million in 2023, then rose by 2.99% to $66.7 million in 2024, then tumbled by 92.78% to $4.8 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $4.8 million (Q4 2025), $472.4 million (Q3 2025), and $590.0 (Q2 2025), per Business Quant data.